BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34867586)

  • 41. Ultrasound-based prediction of cephalic vein cutdown success prior to totally implantable venous access device placement.
    Staszewicz W; Naiken SP; Mennet A; Meyer J; Righini M; Morel P; Toso C
    J Vasc Surg Venous Lymphat Disord; 2019 Nov; 7(6):865-869.e1. PubMed ID: 31495770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
    Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
    J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
    J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Totally implantable vascular access devices in 131 pediatric oncology patients.
    Sola JE; Stone MM; Colombani PM
    Pediatr Surg Int; 1996 Mar; 11(2-3):156-8. PubMed ID: 24057543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
    JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
    El-Balat A; Schmeil I; Karn T; Holtrich U; Mavrova-Risteska L; Rody A; Youssef A; Hanker LC
    In Vivo; 2018; 32(5):1275-1281. PubMed ID: 30150457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?
    Biffi R; Toro A; Pozzi S; Di Carlo I
    Support Care Cancer; 2014 Jun; 22(6):1705-14. PubMed ID: 24659216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychosocial interventions for men with prostate cancer.
    Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma.
    Aribas BK; Yildiz F; Uylar T; Tiken R; Aydin H; Akdulum I; Seber T; Caglar E; Savran B; Aribas O
    J Vasc Access; 2021 Nov; ():11297298211059263. PubMed ID: 34796758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients.
    Dega H; Eliaszewicz M; Gisselbrecht M; Fleury J; Pialoux G; Janssen B; de Saint-Martin L; Gonzalez-Canali G; Dupont B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):146-54. PubMed ID: 8862279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endovascular laser therapy for varicose veins: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(6):1-92. PubMed ID: 23074409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Music interventions for improving psychological and physical outcomes in cancer patients.
    Bradt J; Dileo C; Magill L; Teague A
    Cochrane Database Syst Rev; 2016 Aug; (8):CD006911. PubMed ID: 27524661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implantable venous access devices: an alternative method of extended cancer care.
    Welling RE; Hall JM; Meyer RL; Arbaugh JJ
    J Surg Oncol; 1986 Oct; 33(2):73-5. PubMed ID: 3762187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period.
    Kariyawasam HH; Pepper JR; Hodson ME; Geddes DM
    Respir Med; 2000 Dec; 94(12):1161-5. PubMed ID: 11192950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early and late complications of totally implantable venous access devices.
    Grannan KJ; Taylor PH
    J Surg Oncol; 1990 May; 44(1):52-4. PubMed ID: 2111430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine chest X-ray is not mandatory after fluoroscopy-guided totally implantable venous access device insertion.
    Thomopoulos T; Meyer J; Staszewicz W; Bagetakos I; Scheffler M; Lomessy A; Toso C; Becker CD; Morel P
    Ann Vasc Surg; 2014 Feb; 28(2):345-50. PubMed ID: 24360633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective, international, randomized, noninferiority study comparing an implantable titanium vertebral augmentation device versus balloon kyphoplasty in the reduction of vertebral compression fractures (SAKOS study).
    Noriega D; Marcia S; Theumann N; Blondel B; Simon A; Hassel F; Maestretti G; Petit A; Weidle PA; Mandly AG; Kaya JM; Touta A; Fuentes S; Pflugmacher R
    Spine J; 2019 Nov; 19(11):1782-1795. PubMed ID: 31325625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dance/movement therapy for improving psychological and physical outcomes in cancer patients.
    Bradt J; Shim M; Goodill SW
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007103. PubMed ID: 25565627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.